Nukkleus Inc. Announces Strategic $10.0 Million Private Placement Priced Above-the-Market Under Nasdaq Rules
Nukkleus Inc. Announces Strategic $10.0 Million Private Placement Priced Above-the-Market Under Nasdaq Rules
JERSEY CITY, N.J., Dec. 18, 2024 /PRNewswire/ -- Nukkleus, Inc. (NASDAQ: NUKK), today announced the pricing of a private placement with a single New York-based family office investor. The aggregate gross cash proceeds are expected to be $10.0 million, before deducting fees to the placement agent and other offering expenses payable by the Company. The Company intends to use the net proceeds from the private placement to finance the proposed acquisition of Star 26 Capital Inc., a defense acquisition company holding 95% ownership in RIMON. RIMON is a leading Israeli supplier of components for the Iron Dome missile defense system, as well as other defense and tactical solutions. for general corporate purposes and working capital.
新澤西州澤西城,2024年12月18日 /PRNewswire/ — Nukkleus, Inc.(納斯達克股票代碼:NUKK)今天宣佈了與一家總部位於紐約的家族辦公室投資者進行私募的定價。在扣除向配售代理人支付的費用和公司應付的其他發行費用之前,總現金收益預計爲1,000萬美元。該公司打算使用私募的淨收益爲收購Star 26 Capital Inc. 的擬議收購提供資金。Star 26 Capital Inc.是一家國防收購公司,持有RIMON95%的所有權。RIMON是以色列領先的Iron Dome導彈防禦系統組件以及其他國防和戰術解決方案的供應商。用於一般企業用途和營運資金。
In connection with the private placement, the Company is planning to issue an aggregate of 1,666,666 units (the "Offering"). Each unit will be sold at an effective unit price of $6.00 per unit and will consist of one share of restricted common stock (or one pre-prefunded warrant to purchase a share of restricted common stock), and warrants exercisable for one and one-half shares of restricted common stock, exercisable at $6.00 per share. The Offering is priced above-the-market under Nasdaq rules.
在私募方面,公司計劃共發行1,666,666個單位(「本次發行」)。每個單位將以每單位6.00美元的有效單位價格出售,將包括一股限制性普通股(或一份用於購買限制性普通股的預先籌資認股權證)和可行使一股半限制性普通股的認股權證,可按每股6.00美元的價格行使。根據納斯達克的規定,本次發行的價格高於市場。
The closing of the private placement is expected to occur on or about December 19, 2024, subject to the satisfaction of certain customary closing conditions.
私募預計將於2024年12月19日左右完成,但須滿足某些慣例成交條件。
Dawson James Securities is acting as the Exclusive Placement Agent for the private placement.
道森詹姆斯證券擔任此次私募的獨家配售代理。
The securities described above are being sold in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended (the "Act"), and have not been registered under the Act, or applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Act and such applicable state securities laws. Pursuant to a registration rights agreement with the investor, the Company has agreed to file one or more registration statements with the Securities and Exchange Commission (the "SEC") covering the resale of the common stock sold in the private placement and the common stock issuable upon exercise of the pre-funded warrants and the warrants sold in the private placement.
上述證券以私募方式出售,不受經修訂的1933年《證券法》(「該法」)的註冊要求的約束,並且尚未根據該法或適用的州證券法進行註冊。因此,除非根據有效的註冊聲明或該法和相應的州證券法註冊要求的適用豁免,否則不得在美國發行或出售這些證券。根據與投資者簽訂的註冊權協議,公司已同意向美國證券交易委員會(「SEC」)提交一份或多份註冊聲明,涵蓋私募中出售的普通股以及行使預先注資認股權證後可發行的普通股和私募中出售的認股權證。
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
本新聞稿不構成出售要約或徵求購買本文所述任何證券的要約,在根據任何此類州或司法管轄區的證券法進行註冊或獲得資格認證之前,在任何州或司法管轄區出售此類證券是非法的,也不應在任何州或司法管轄區出售這些證券。
About Nukkleus, Inc.
關於 Nukkleus, Inc.
Nukkleus, Inc. (NASDAQ: NUKK) is a Nasdaq company, recently announced an acquisition of Star 26 Capital Inc – a defense-focused acquisition company.
Nukkleus, Inc.(納斯達克股票代碼:NUKK)是一家納斯達克公司,最近宣佈收購以國防爲重點的收購公司Star 26 Capital Inc.
Forward-Looking Statements
前瞻性陳述
This press release contains forward-looking statements. All statements other than statements of historical facts are "forward-looking statements" within the meaning of federal securities laws. In some cases, you can identify forward-looking statements by terminology such as "will," "would," "expect," "intend," "plan," "objective," or comparable terminology referencing future events, conditions or circumstances, or the negative of such terms. Although Nukkleus believes that it has a reasonable basis for the forward-looking statements contained in this press release, they are based on management's current beliefs and expectations about future events and circumstances and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond the Company's control. Risk factors described under "Risk Factors" in Nukkleus' most recently filed annual report on Form 10-K, as updated from time to time in its quarterly reports on Form 10-Q and other filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements in this press release. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Nukkleus undertakes no obligation to update any forward-looking statement contained in this press release to reflect events that occur or circumstances that exist after the date of this press release, except as required by law.
本新聞稿包含前瞻性陳述。根據聯邦證券法,除歷史事實陳述以外的所有陳述均爲 「前瞻性陳述」。在某些情況下,您可以使用 「將」、「將」、「期望」、「打算」、「計劃」、「目標」 等術語來識別前瞻性陳述,或引用未來事件、條件或情況的類似術語或此類術語的否定詞。儘管Nukkleus認爲本新聞稿中包含的前瞻性陳述有合理的依據,但這些陳述是基於管理層當前對未來事件和情況的看法和預期,並受到風險和不確定性的影響,所有這些都難以預測,其中許多是公司無法控制的。Nukkleus最近提交的10-k表年度報告中的 「風險因素」 下描述的風險因素可能導致實際業績、業績或成就與本新聞稿中前瞻性陳述所表達或暗示的結果存在重大差異,這些風險因素可能導致實際業績、業績或成就與本新聞稿中前瞻性陳述所表達或暗示的結果存在重大差異。提醒您不要過分依賴前瞻性陳述,前瞻性陳述僅代表其發表之日。除非法律要求,否則Nukkleus沒有義務更新本新聞稿中包含的任何前瞻性陳述以反映本新聞稿發佈之日之後發生的事件或存在的情況。
SOURCE Nukkleus, Inc.
來源 Nukkleus, Inc.